comparemela.com

Latest Breaking News On - Targeting transcription factor - Page 1 : comparemela.com

Foghorn Therapeutics to Highlight Transcription Factor and Protein Degradation Capabilities at the 18th Annual Drug Discovery Chemistry Meeting

CAMBRIDGE, Mass., April 06, 2023 Foghorn® Therapeutics Inc. , a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting. | April 6, 2023

United kingdomSan diegoUnited statesHilton bayfrontKarin hellsvikMatthew nethertonAsadm taherbhoyMichael lampeHans vitzthumFoghorn therapeutics incTherapeutics incExchange commissionCompany annual report on formCompany phaseAnnual drug discovery chemistryTargeting transcription factor

Foghorn Therapeutics to Highlight Transcription Factor and Protein Degradation Capabilities at the 18th Annual Drug Discovery Chemistry Meeting

CAMBRIDGE, Mass., April 06, 2023 Foghorn® Therapeutics Inc. , a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal. | June 20, 2023

United kingdomSan diegoUnited statesMatthew nethertonKarin hellsvikHilton bayfrontHans vitzthumMichael lampeAsadm taherbhoyCompany annual report on formCompany phaseExchange commissionFoghorn therapeutics incTherapeutics incAnnual drug discovery chemistryTargeting transcription factor

vimarsana © 2020. All Rights Reserved.